SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19585393
Source:
http://linkedlifedata.com/resource/pubmed/id/19585393
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0013919
,
umls-concept:C0032893
,
umls-concept:C0040711
,
umls-concept:C0080356
,
umls-concept:C0171023
,
umls-concept:C0205210
,
umls-concept:C1707455
,
umls-concept:C2587213
,
umls-concept:C2603343
,
umls-concept:C2607943
,
umls-concept:C2926606
pubmed:issue
4
pubmed:dateCreated
2009-7-8
pubmed:abstractText
The aim of this study was to compare the outcomes of olanzapine- and valproate-treated patients in an observational study of acute mania with the results of a randomised controlled trial (RCT) assessing the same treatments.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8402938
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Antimanic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines
,
http://linkedlifedata.com/resource/pubmed/chemical/Valproic Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/olanzapine
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1439-0795
pubmed:author
pubmed-author:BertschJJ
,
pubmed-author:EMBLEM Advisory Board
,
pubmed-author:Gonzalez-PintoAA
,
pubmed-author:HartJ PJP
,
pubmed-author:NovickDD
,
pubmed-author:PerrinEE
,
pubmed-author:ReedCC
,
pubmed-author:TohenMM
pubmed:issnType
Electronic
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
145-52
pubmed:meshHeading
pubmed-meshheading:19585393-Adult
,
pubmed-meshheading:19585393-Antidepressive Agents
,
pubmed-meshheading:19585393-Antimanic Agents
,
pubmed-meshheading:19585393-Benzodiazepines
,
pubmed-meshheading:19585393-Bipolar Disorder
,
pubmed-meshheading:19585393-Female
,
pubmed-meshheading:19585393-Gastrointestinal Diseases
,
pubmed-meshheading:19585393-Humans
,
pubmed-meshheading:19585393-Male
,
pubmed-meshheading:19585393-Prospective Studies
,
pubmed-meshheading:19585393-Psychiatric Status Rating Scales
,
pubmed-meshheading:19585393-Randomized Controlled Trials as Topic
,
pubmed-meshheading:19585393-Treatment Outcome
,
pubmed-meshheading:19585393-Valproic Acid
,
pubmed-meshheading:19585393-Weight Gain
pubmed:year
2009
pubmed:articleTitle
Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study.
pubmed:affiliation
Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, UK. Novick_diego@lilly.com
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't